Pds Planning, Inc Novo Nordisk A S Transaction History

Pds Planning, Inc

$1.45 Billion
Q4 2025

A detailed history of Pds Planning, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Pds Planning, Inc holds 14,376 shares of NVO stock, worth $696,660. This represents 0.05% of its overall portfolio holdings.

Number of Shares

14,376

Previous 11,737 22.48%

Holding current value

$696,660

Previous $651,000 6.91%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 26, 2026	BUY	$45.68 - $59.65 $120,549 - $157,416	2,639 Added 22.48%	14,376 $696,000
Q3 2025 Oct 21, 2025	SELL	$45.38 - $71.7 $81,956 - $129,490	-1,806 Reduced 13.34%	11,737 $651,000
Q2 2025 Jul 24, 2025	SELL	$58.08 - $81.05 $17,946 - $25,044	-309 Reduced 2.23%	13,543 $934,000
Q1 2025 Apr 23, 2025	BUY	$69.3 - $90.95 $37,837 - $49,658	546 Added 4.1%	13,852 $961,000
Q4 2024 Feb 10, 2025	BUY	$85.0 - $120.04 $15,640 - $22,087	184 Added 1.4%	13,306 $1.14 Million

Q3 2024 Oct 29, 2024	BUY	$119.07 - $145.42 $86,087 - $105,138	723 Added 5.83%	13,122 $1.56 Million
Q2 2024 Aug 07, 2024	BUY	$122.71 - $146.91 $30,800 - $36,874	251 Added 2.07%	12,399 $1.77 Million
Q1 2024 May 01, 2024	BUY	$102.11 - $135.92 $41,660 - $55,455	408 Added 3.48%	12,148 $1.56 Million
Q4 2023 Feb 01, 2024	BUY	$87.78 - $105.45 $4,915 - $5,905	56 Added 0.48%	11,740 $1.21 Million
Q3 2023 Oct 20, 2023	BUY	$90.94 - $199.54 $562,554 - $1.23 Million	6,186 Added 112.51%	11,684 $1.06 Million
Q2 2023 Jul 20, 2023	BUY	$155.98 - $172.65 $21,213 - $23,480	136 Added 2.54%	5,498 $889,000
Q1 2023 May 01, 2023	BUY	$132.34 - $159.14 $217,037 - $260,989	1,640 Added 44.06%	5,362 $853,000
Q4 2022 Jan 26, 2023	BUY	$102.55 - $135.33 $9,434 - $12,450	92 Added 2.53%	3,722 $0
Q3 2022 Nov 02, 2022	SELL	$95.28 - $116.93 $11,719 - $14,382	-123 Reduced 3.28%	3,630 $362,000
Q2 2022 Jul 15, 2022	BUY	$103.24 - $121.81 $102,104 - $120,470	989 Added 35.78%	3,753 $418,000
Q1 2022 Apr 18, 2022	BUY	$93.1 - $112.54 $39,381 - $47,604	423 Added 18.07%	2,764 $307,000
Q4 2021 Jan 25, 2022	SELL	$95.88 - $117.08 $23,778 - $29,035	-248 Reduced 9.58%	2,341 $262,000
Q3 2021 Oct 22, 2021	SELL	$84.42 - $106.62 $10,552 - $13,327	-125 Reduced 4.61%	2,589 $249,000
Q2 2021 Jul 26, 2021	BUY	$67.66 - $84.76 $183,629 - $230,038	2,714 New	2,714 $227,000

Others Institutions Holding NVO

# of Institutions

1,687

Shares Held

304M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.

Account